All In MedTech

Device Trial Radar · NCT06952816

Automated Oxygen Titration With the EMILY.AI Device in a Respiratory Intermediate Care Unit

Functional, Clinical, and Predictive Validation Study of the EMILY AI Device in Patients With Acute and Chronic Respiratory Failure: Respiratory Intermediate Care Unit Substudy

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Suspended

Status

Suspended

Enrollment

80

Planned (sponsor's estimate)

Start

Apr 15, 2025

Primary completion

Mar 30, 2027

Study completion Mar 30, 2027

Sponsor

Lead sponsor
Aether Tech S.L.Not on our public-company list
Sponsor type
Industry
Collaborators
Hospital Universitario Fundación Jiménez Díaz
First posted
May 1, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Sequential
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates EMILY.AI, an investigational (non-CE-marked) smart oxygen valve that automatically adjusts the oxygen flow delivered to a patient. Adults with acute respiratory failure admitted to the Respiratory Intermediate Care Unit (RICU) of Hospital Universitario Fundación Jiménez Díaz (Madrid, Spain) receive oxygen titrated automatically by EMILY.AI and, in the same monitoring session, oxygen titrated manually by the nursing team while the device records saturation and flow. The study measures how much of the time patients stay within their target saturation range under each method, how fast the device corrects deviations, the alerts it generates, nursing workload, oxygen use and patient comfort. This substudy is part of clinical investigation FJD-EMILY-23-02, whose other substudies are registered in separate records.

Conditions

  • Chronic Respiratory Failure
  • Acute Respiratory Failure
  • Hypoxemic Respiratory Failure
  • Hypercapnic Respiratory Failure
  • Acute-on-chronic Respiratory Failure

Interventions

  • Emily.AIDevice

    Investigational smart oxygen valve with a rule-based algorithm that adjusts oxygen flow to keep SpO2 within a target range. Other names: EMILY.AI Smart Valve

  • Manual oxygen titrationOther

    Standard care: oxygen flow set and adjusted by the unit's nursing team according to usual practice. The EMILY.AI device stays connected and records signals and flow but does not control delivery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. EFFICACY - EVALUATION OF THE RATE THE DEVICE MAINTAINS BLOOD OXYGEN SATURATION LEVELSTime frame: During the monitoring session: approximately 5 hours of closed-loop titration followed by approximately 5 hours of manual titration on the same day (closed-loop period only in the initial phase).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.